Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Hypertension. 2023 Mar 2;80(5):1048–1056. doi: 10.1161/HYPERTENSIONAHA.122.20354

Table 2:

Blood pressure status and characteristics by age for 3550 person-visits contributed by 902 participants. Hypertensive status was defined using clinic data, based on current American Academy of Pediatrics (AAP) guidelines12. Clinic BP was classified as normal, elevated, stage 1 hypertensive BP, or stage 2 hypertensive BP.

Characteristics* 0 to <7 yrs, n=524 ≥7 to <13 yrs, n=1354 ≥13 to ≤18 yrs, n=1672
Systolic BP percentile 76 [50, 91] 67 [38, 89] 52 [24, 76]
Systolic BP status
 <90th percentile 71% (374) 77% (1037) 87% (1457)
 ≥90th to <95th percentile 10% (50) 8% (106) 5% (89)
 ≥95th percentile 19% (100) 15% (211) 8% (126)
Diastolic BP percentile 82 [60, 94] 65 [44, 86] 57 [31, 82]
Diastolic BP status
 <90th percentile 64% (336) 80% (1078) 84% (1403)
 ≥90th to <95th percentile 13% (66) 7% (99) 6% (96)
 ≥95th percentile 23% (122) 13% (177) 10% (173)
Blood pressure status
 Normal 54% (282) 67% (909) 73% (1219)
 Elevated 14% (76) 11% (151) 11% (189)
 Stage 1 hypertensive BP 28% (144) 18% (246) 12% (199)
 Stage 2 hypertensive BP 4% (21) 4% (48) 4% (65)
 Hypertensive BP (stages 1 & 2) 32% (166) 22% (294) 16% (264)
Current use of antihypertensive medication 45% (234) 65% (878) 72% (1201)
Current use of ACEi/ARB 31% (162) 55% (748) 61% (1023)
Self-reported hypertension 32% (165) 46% (624) 47% (783)
*

Reported as median [IQR] for continuous variables and percent (n) for categorical variables. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker.